Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Get research updatesThis study has an unknown status in Israel. It is testing methylphenidate for ADHD.
Listed age limits: 21 years to 50 years.
Compensation and expense reimbursement have not been verified for this summary.
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Hod HaSharon
Borderline Personality Disorder
A listed location does not confirm current availability.
The study sponsor is Shalvata Mental Health Center, a hospital or academic medical center.
Yes. The study involves medication, including methylphenidate.
Listed age limits: 21 years to 50 years.
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me